Stock PLX PROTALIX BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Protalix BioTherapeutics, Inc.

Equities

PLX

US74365A3095

Market Closed - Nyse
Other stock markets
 04:00:00 2024-06-12 pm EDT 		5-day change 1st Jan Change
1.18 USD 0.00% Intraday chart for Protalix BioTherapeutics, Inc. 0.00% -33.71%
May. 10 Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024
May. 10 Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PROTALIX BIOTHERAPEUTICS, INC. Stock Protalix BioTherapeutics, Inc.
 86.51M - -
MODERNA, INC. Stock Moderna, Inc.
 56.87B -
LONZA GROUP AG Stock Lonza Group AG
 39.72B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.27B
CELLTRION, INC. Stock Celltrion, Inc.
 28.73B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.21B
  1. Stock Market
  2. Equities
  3. PLX Stock
  4. Charts Protalix BioTherapeutics, Inc.
  5. Sector Chart